. . . . . . . "[In addition, 131I-TQM13 demonstrated in vivo efficacy against subcutaneous IL13R?2-expressing GBM tumors and in an orthotopic synergeic IL13R?2-positive murine glioma model, as evidenced by statistically significant survival advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:56+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .